Latest News and Press Releases
Want to stay updated on the latest news?
-
WINNIPEG, MANITOBA--(Marketwire - Jan. 31, 2013) - Kane Biotech Inc. (TSX VENTURE:KNE), will launch its marketing field test for StrixNB, its revolutionary new pet oral care product, in...
-
WINNIPEG, MANITOBA--(Marketwire - Dec. 14, 2012) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation") today announced closing of the Corporation's previously announced non-brokered...
-
WINNIPEG, MANITOBA--(Marketwire - Nov. 28, 2012) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company developing and commercializing products that prevent and remove microbial...
-
WINNIPEG, MANITOBA--(Marketwire - Nov. 27, 2012) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...
-
WINNIPEG, MANITOBA--(Marketwire - Nov. 20, 2012) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...
-
WINNIPEG, MANITOBA--(Marketwire - Nov. 15, 2012) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...
-
WINNIPEG, MANITOBA--(Marketwire - Nov. 14, 2012) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation") today announced the intention of the Corporation to undertake a non-brokered...
-
WINNIPEG, MANITOBA--(Marketwire - Nov. 6, 2012) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...
-
WINNIPEG, MANITOBA--(Marketwire - Oct. 25, 2012) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...
-
WINNIPEG, MANITOBA--(Marketwire - Oct. 16, 2012) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...